Monoclonal Antibody APIs-Wuhan Sunrise Technology

中文版　英文版

Product Categories

5-Bromoacetyl-2-hydroxybenzaldehyde

6-N-Benzylamino-1-(4’-phenylbutoxy)Hexane

(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide

Products

Product	CAS No.	Purity
Ibritumomab tiuxetan	206181-63-7	97% (API grade)
Infliximab	170277-31-3	97% (API grade)
Ipilimumab	477202-00-9	97% (API grade)
Muromonab-CD3	140608-64-6	97% (API grade)
Natalizumab	189261-10-7	97% (API grade)
Ofatumumab	679818-59-8	97% (API grade)
Omalizumab	242138-07-4	97% (API grade)
Palivizumab	188039-54-5	97% (API grade)
Panitumumab	339177-26-3	97% (API grade)
Ranibizumab	347396-82-1	97%(API grade)
Tocilizumab	375823-41-9	97% (API grade)
Avelumab	1537032-82-8	97%(API grade)
Ramucirumab	947687-13-0	97%(API grade)
Daratumumab	945721-28-8	97%(API grade)
Vedolizumab	943609-66-3	97%(API grade)
Caplacizumab	915810-67-2	97%(API grade)
Elotuzumab	915296-00-3	97%(API grade)
Romosozumab	909395-70-6	97%(API grade)
Necitumumab	906805-06-9	97%(API grade)
Blinatumomab	853426-35-4	97%(API grade)

1 2 3

Copyright © Wuhan Sunrise Technology Development Company Limited All rights reserved. 2012.Supported by www.hxchem.net